Catheter Precision logo

Catheter Precision (VTAK) Q1 2026 Annual Earnings

VTAK·Reported May 18, 2026·After market close

Catheter Precision reported Q1 2026 revenue of $432.0K (+202.1% YoY), missed analyst consensus of $1.6M by $1.2M. Diluted EPS came in at $-1.39 (-286.1% YoY), beat the $-20.90 consensus by $19.51.

Revenue
$432.0Kmissed by $1.2M
Consensus: $1.6M
Diluted EPS
$-1.39beat by $19.51
Consensus: $-20.90
SEC

SEC Filings

Earnings release8-K · 0001437749-26-017612
Annual report10-K · 0001437749-26-010549

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Catheter Precision's Q1 2026 earnings report.

Catheter Precision (VTAK) reported Q1 2026 earnings on May 18, 2026 after market close.

Catheter Precision reported revenue of $432.0K and diluted EPS of $-1.39 for Q1 2026.

Revenue missed the consensus estimate of $1.6M by $1.2M. EPS beat the consensus estimate of $-20.90 by $19.51.

Compared to the same quarter a year prior, revenue grew 202.1% from $143.0K a year earlier and diluted EPS declined 286.1% from $-0.36.

You can read the 8-K earnings release (0001437749-26-017612) and the 10-K periodic report (0001437749-26-010549) directly on SEC EDGAR. The filing index links above go to sec.gov.